Nonin Medical Inc. Announces Entry Into the Cerebral Oxime... ( MINNEAPOLIS July 22 /- Nonin Medi...)

Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market

Date:7/22/2008

MINNEAPOLIS, July 22 /PRNewswire/ -- Nonin Medical, a leading innovator of physiological monitoring solutions for more than 20 years, has entered the clinical testing phase with its breakthrough technology to measure regional oxygen saturation. Today's most common application for this technology is the continuous monitoring of the regional blood oxygenation in the brain -- cerebral oximetry.

Early testing data and outcomes from an ongoing clinical study at the Duke University Medical Center have yielded favorable results. These data results support the objective to simplify sensor application while improving the usefulness of the measurement.

For over two decades, Nonin Medical has remained at the forefront of noninvasive physiological monitoring with specific focus on highly effective signal processing and the advancement of innovative pulse oximeter products. With the introduction of the Onyx(R), the world's first fingertip pulse oximeter, Nonin Medical changed the global market for oximetry. Today, Nonin Medical has the largest installed base of pulse oximeters in the industry with well over one million units worldwide.

"This invaluable clinical and technical experience combined with a vision for the future has enabled us to develop a product that promises to advance the field of patient monitoring, once again," said Gary Tschautscher, CEO and President of Nonin Medical. "We understand the immense pressure on the healthcare market to reduce the cost of patient care while providing new, more effective, yet simple solutions. Our newly developed sensor and patented signal processing technology is designed to deliver on these objectives."

The advanced modular design of this new technology permits future expansion of functionality, while also permitting product and data integration into other monitoring systems. This clearly aligns with Nonin Medical's vision for interoperability and facilitating information flow without the need of
'/>"/>

SOURCE Nonin Medical
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
2. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
3. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
4. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
5. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
6. Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
7. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
8. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
9. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
10. Oridion Announces Major Medical Research and Congress Presentations
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies

Post Your Comments:

(Date:5/17/2013)... Conn. , May 17, 2013 /PRNewswire-iReach/ -- ... and recombinant proteins, is placing renewed emphasis on ... the rise as a number of factors are ... for pharmaceutical makers and their delivery device partners ... previously refractory conditions, the growing trend toward self-administration ...

(Date:5/17/2013)... May 17, 2013 Boehringer Ingelheim will contribute ... at the American Thoracic Society International Conference (ATS ... May 17 – 22. Data will ... the treatment of chronic obstructive pulmonary disease (COPD) ... as investigational compounds for asthma, idiopathic pulmonary fibrosis ...

(Date:5/17/2013)... 2013 Sanofi (EURONEXT: SAN and NYSE: SNY ... JAKARTA , examining the selective JAK2 inhibitor SAR302503 ... dose groups. The primary endpoint assessed the proportion of ... data reported in previous trials, the most common adverse ... will be presented at an upcoming medical congress. ...

Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2 Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5 Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6

[0] Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment [0] Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference [0] Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis

... 12, 2011 Unilife Corporation ("Unilife" or the "Company") ... the development of its AutoInfusor™ portfolio of subcutaneous infusion ... 5mL, 7mL, and 10mL volumes. Unilife has ... of pharmaceutical and biotechnology companies with drugs that have ...

... one of the largest distributors of high-performance and engineering-grade ... new EVONIK VESTAKEEP® 5000 PEEK extruded stock shapes. ... most ductility of any PEEK material available in extruded ... Marketing at Modern Plastics. EVONIK VESTAKEEP® ...

Cached Medicine Technology:Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 2 Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 3 Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients 4

Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients Modern Plastics Announces New EVONIK VESTAKEEP® 5000 PEEK Stock Shapes

(Date:5/18/2013)... PA (PRWEB) May 18, 2013 Simple ... indulging in healthy snacks and drinking more water can ... loss and, ultimately, a healthier lifestyle overall. Diet ... achieve the best weight loss can be difficult and ... into their diet plans to help patients get over ...

(Date:5/18/2013)... Adolescents, especially young males, who experiment ... “K2” are landing in emergency rooms across America. ... epidemic with a new treatment program for those ... research from the National Institute on Drug Abuse, synthetic ... American teenagers. In 2012, 11 percent of high school ...

(Date:5/18/2013)... Francisco, CA (PRWEB) May 18, 2013 ... appointments for 2013 therapies. At the Ayurvedic Spa ... guidance of panchakarma practitioner and lifestyle recommendations ... Ayurveda, the “knowledge of life", is the traditional healthcare ... that a life of harmony is the basis for ...

(Date:5/18/2013)... May 18, 2013 Losing weight remains to ... among the horde of new weight loss products available in ... about. Recent studies about this newest weight loss supplement prove ... body shape. , Garcinia Cambogia is a sub-tropical fruit that ... Eating the fruit can suppress a person’s appetite, while it ...

(Date:5/18/2013)... Scott Tischler of Tischler Brothers Fitness helped Troy Tischler ... losing weight played a huge part in Troy Tischler's weight ... was able to lose a pound a day. It is ... approached with caution and any activity should be stopped if ... weight loss that Scott Tischler advocates. With these five keys ...

Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3 Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2 Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2 Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2

[0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments [0] Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates [0] Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center [0] Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com [0] Scott R. Tischler of Tischler Brothers Fitness unveils how to lose a pound a day this summer

... Network, the prominent advocacy group launches the inaugural World ... site, www.worldmrsaday.org . MRSA activists ... and the community for a greater response to the ... alarming rate.MRSA Survivors Network, the official organization for World ...

... 5 The World Health Organization says a Swine ... already declared emergencies. Many experts believe the Federal government ... the outbreak takes on the public will become increasing ... of panic. Your only defense: to prepare your department ...

... Give Voice to Improving Quality Care and Quality Careers , ... for better senior living, celebrates National Nurse Week May 6-12, ... how to improve the business, the quality of care and ... Vigilan is offering an online and phone-based survey where ...

... Indiana University School of Medicine , the not-for-profit Taking Control ... for people living with diabetes on May 30 from 9 ... The TCOYD conference, lunch and health fair brings national and ... types of diabetes, those at risk for diabetes, and their ...

... Society of Cellular Therapy (ISCT) Demonstrating Potential to ... in TransplantationOLDSMAR, Fla., May 5 /PRNewswire-FirstCall/ -- ... new study showing that adding menstrual blood stem ... blood expands the number of progenitor cells (cells ...

... Inc. (Nasdaq: CYNO ), a ... light-based aesthetic treatment systems, today announced financial results for ... 2009 Financial Results , Consistent with Cynosure,s ... March 31, 2009 were $14.8 million, reflecting the continued ...

MRSA Activists Rally For World MRSA Day Ready or Not - Flu Pandemic Has Arrived Vigilan Honors National Nurse Week in Assisted Living, Independent Living and Dementia Care Taking Control of Your Diabetes Conference Returns to Indianapolis to Bring Answers, Advocacy and Hope for People With Diabetes Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells Cynosure Reports Financial Results for the First Quarter of 2009

Prolactin EIA Reproductive Markers 025-BC-1037...

FSH EIA Reproductive Markers 025-BC-1029 Follicle Stimulating Hormone...

... (pregn-4-ene-3, 20-dione) is a C21 steroid hormone ... bond between C-4 and C-5 (?4).,This steroid ... in conjunction with estrogens, regulates,the accessory organs ... particularly important in preparing the,endometrium for the ...

... also known as Kininase II, is a ... weight of at least 129,000. The structure ... chain, a polysaccharide residue and a zinc ... cell types such as neuronal cells and ...

Medicine Products:

Prolactin EIA Reproductive Markers 025-BC-1037 FSH EIA Reproductive Markers 025-BC-1029 Follicle Stimulating Hormone Progesterone EIA Reproductive Markers 020-DR-1561 ACE - REA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-ACD Angiotensin Converting Enzyme